|
Volumn 63, Issue 3, 2004, Pages 466-471
|
Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer.
a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALKYLATING AGENT;
MITOMYCIN;
AGED;
ARTICLE;
BLADDER TUMOR;
CANCER STAGING;
CARCINOMA IN SITU;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CYSTECTOMY;
CYSTOSCOPY;
DISEASE COURSE;
DISEASE FREE SURVIVAL;
FEMALE;
FOLLOW UP;
HUMAN;
HYPERTHERMIC THERAPY;
INTRAVESICAL DRUG ADMINISTRATION;
MALE;
MIDDLE AGED;
MULTICENTER STUDY;
MULTIMODALITY CANCER THERAPY;
PATHOLOGY;
TRANSITIONAL CELL CARCINOMA;
TUMOR RECURRENCE;
ADMINISTRATION, INTRAVESICAL;
AGED;
AGED, 80 AND OVER;
ANTINEOPLASTIC AGENTS, ALKYLATING;
CARCINOMA IN SITU;
CARCINOMA, TRANSITIONAL CELL;
COMBINED MODALITY THERAPY;
CYSTECTOMY;
CYSTOSCOPY;
DISEASE PROGRESSION;
DISEASE-FREE SURVIVAL;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
HYPERTHERMIA, INDUCED;
MALE;
MIDDLE AGED;
MITOMYCIN;
NEOPLASM RECURRENCE, LOCAL;
NEOPLASM STAGING;
URINARY BLADDER NEOPLASMS;
MLCS;
MLOWN;
|
EID: 2942683157
PISSN: None
EISSN: 15279995
Source Type: Journal
DOI: 10.1016/j.urology.2003.10.036 Document Type: Article |
Times cited : (103)
|
References (0)
|